Literature DB >> 31426089

Disclosure of Interests and Management of Conflicts of Interest in Clinical Guidelines and Guidance Statements: Methods From the Clinical Guidelines Committee of the American College of Physicians.

Amir Qaseem1, Timothy J Wilt2, Mary Ann Forciea, Devan Kansagara, Carolyn J Crandall, Nick Fitterman, Lauri A Hicks, Carrie A Horwitch, Jennifer S Lin, Michael Maroto, Robert M McLean, Reem A Mustafa, Jairo Roa, Janice Tufte, Sandeep Vijan.   

Abstract

One of the hallmarks of a trustworthy clinical guideline or guidance statement is a comprehensive process for disclosure of interests (DOI) and management of conflicts of interest (COIs). The American College of Physicians (ACP) Clinical Guidelines Committee (CGC) aims to disclose all health care-related interests and manage conflicts in a manner that is transparent, proportional, and consistent. Any person involved in the development of an ACP clinical guideline or guidance statement must disclose all financial and intellectual interests related to health care from the previous 3 years. Persons complete disclosures at the start of their participation and are required to update them over the course of their involvement with the CGC, including before each CGC meeting. A DOI-COI Review and Management Panel reviews the disclosures; flags potential conflicts; grades the COI as low-, moderate-, or high-level; and manages the person's participation accordingly. A high-level COI results in recusal from authorship, voting, and all committee discussions. Participants with a moderate-level COI are recused from authorship and voting for clinically relevant topics but may participate in all discussions. A low-level COI results in no role restrictions. All disclosures and COI management decisions are publicly reported.

Entities:  

Mesh:

Year:  2019        PMID: 31426089     DOI: 10.7326/M18-3279

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  11 in total

Review 1.  Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians.

Authors:  Amir Qaseem; Carolyn J Crandall; Reem A Mustafa; Lauri A Hicks; Timothy J Wilt; Mary Ann Forciea; Nick Fitterman; Carrie A Horwitch; Devan Kansagara; Michael Maroto; Robert M McLean; Jairo Roa; Janice Tufte
Journal:  Ann Intern Med       Date:  2019-11-05       Impact factor: 25.391

2.  Analysis of conflicts of interest among authors and researchers of European clinical guidelines in cardiovascular medicine.

Authors:  Jonathan Hinton; Thomas Reeves; Benoy N Shah
Journal:  Clin Med (Lond)       Date:  2021-03       Impact factor: 2.659

3.  Conflicts of Interest and the Trustworthiness of Clinical Practice Guidelines.

Authors:  Anna Mathew; Catherine M Clase
Journal:  Clin J Am Soc Nephrol       Date:  2022-05-27       Impact factor: 10.614

4.  Associations Between Aggregate NLP-Extracted Conflicts of Interest and Adverse Events by Drug Product.

Authors:  S Scott Graham; Zoltan P Majdik; Johua B Barbour; Justin F Rousseau
Journal:  Stud Health Technol Inform       Date:  2022-06-06

Review 5.  2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group.

Authors:  Michelle M Cloutier; Alan P Baptist; Kathryn V Blake; Edward G Brooks; Tyra Bryant-Stephens; Emily DiMango; Anne E Dixon; Kurtis S Elward; Tina Hartert; Jerry A Krishnan; Robert F Lemanske; Daniel R Ouellette; Wilson D Pace; Michael Schatz; Neil S Skolnik; James W Stout; Stephen J Teach; Craig A Umscheid; Colin G Walsh
Journal:  J Allergy Clin Immunol       Date:  2020-12       Impact factor: 10.793

6.  Managing conflicts of interest in the development of health guidelines.

Authors:  Gregory Traversy; Lianne Barnieh; Elie A Akl; G Michael Allan; Melissa Brouwers; Isabelle Ganache; Quinn Grundy; Gordon H Guyatt; Diane Kelsall; Gillian Leng; Ainsley Moore; Navindra Persaud; Holger J Schünemann; Sharon Straus; Brett D Thombs; Rachel Rodin; Marcello Tonelli
Journal:  CMAJ       Date:  2021-01-11       Impact factor: 8.262

7. 

Authors:  Gregory Traversy; Lianne Barnieh; Elie A Akl; G Michael Allan; Melissa Brouwers; Isabelle Ganache; Quinn Grundy; Gordon H Guyatt; Diane Kelsall; Gillian Leng; Ainsley Moore; Navindra Persaud; Holger J Schünemann; Sharon Straus; Brett D Thombs; Rachel Rodin; Marcello Tonelli
Journal:  CMAJ       Date:  2021-03-01       Impact factor: 8.262

8.  The reporting checklist for public versions of guidelines: RIGHT-PVG.

Authors:  Xiaoqin Wang; Yaolong Chen; Elie A Akl; Ružica Tokalić; Ana Marušić; Amir Qaseem; Yngve Falck-Ytter; Myeong Soo Lee; Madelin Siedler; Sarah L Barber; Mingming Zhang; Edwin S Y Chan; Janne Estill; Joey S W Kwong; Akiko Okumura; Qi Zhou; Kehu Yang; Susan L Norris
Journal:  Implement Sci       Date:  2021-01-11       Impact factor: 7.327

9.  Standards Required for the Development of CDC Evidence-Based Guidelines.

Authors:  Vilma Carande-Kulis; Randy W Elder; Dyann Matson- Koffman
Journal:  MMWR Suppl       Date:  2022-01-14

10.  Examining the sources of evidence in e-cigarette policy recommendations: A citation network analysis of international public health recommendations.

Authors:  Marissa J Smith; Andrew J Baxter; Kathryn Skivington; Mark McCann; Shona Hilton; Srinivasa Vittal Katikireddi
Journal:  PLoS One       Date:  2021-08-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.